340
Views
30
CrossRef citations to date
0
Altmetric
Reviews

In vitro and in vivo biological activity of PEDF against a range of tumors

, Bsc (Med) MBBS, , PhD & , MBBS MD FRACS FAOrthA
Pages 1429-1438 | Published online: 04 Oct 2009

Bibliography

  • Becerra SP. Focus on molecules: pigment epithelium-derived factor (PEDF). Exp Eye Res 2006;82(5):739-40
  • Tombran-Tink J, Johnson LV. Neuronal differentiation of retinoblastoma cells induced by medium conditioned by human RPE cells. Invest Ophthalmol Vis Sci 1989;30(8):1700-7
  • Becerra SP. Structure–function studies on PEDF. A noninhibitory serpin with neurotrophic activity. Adv Exp Med Biol 1997;425:223-37
  • Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Exp Eye Res 1991;53(3):411-4
  • Ek ET, Dass CR, Choong PF. PEDF: a potential molecular therapeutic target with multiple anti-cancer activities. Trends Mol Med 2006;12(10):497-502
  • Tombran-Tink J, Barnstable CJ. Therapeutic prospects for PEDF: more than a promising angiogenesis inhibitor. Trends Mol Med 2003;9(6):244-50
  • Quan GM, Choong PF. Anti-angiogenic therapy for osteosarcoma. Cancer Metastasis Rev 2006;25(4):707-13
  • Dawson DW, Volpert OV, Gillis P, Pigment epithelium-derived factor: a potent inhibitor of angiogenesis. Science 1999;285(5425):245-8
  • Maik-Rachline G, Shaltiel S, Seger R. Extracellular phosphorylation converts pigment epithelium-derived factor from a neurotrophic to an antiangiogenic factor. Blood 2005;105(2):670-8
  • Ren JG, Jie C, Talbot C. How PEDF prevents angiogenesis: a hypothesized pathway. Med Hypotheses 2005;64(1):74-8
  • Becerra SP, Sagasti A, Spinella P, Notario V. Pigment epithelium-derived factor behaves like a noninhibitory serpin. Neurotrophic activity does not require the serpin reactive loop. J Biol Chem 1995;270(43):25992-9
  • Zhang L, Chen J, Ke Y, Down-regulation of PEDF expression by ribozyme transgene in endothelial and lung cancer cells and its impact on angiogenesis in vitro. Oncol Rep 2005 2005;14(6):1615-9
  • Zhang LJ, Chen JF, Lu AP, Expression of placental growth factor and pigment epithelium-derived factor in non-small cell lung cancer and the prognostic significance thereof. Zhonghua Yi Xue Za Zhi 2005;85(47):3328-31
  • Zhang L, Chen J, Ke Y, Expression of pigment epithelial derived factor is reduced in non-small cell lung cancer and is linked to clinical outcome. Int J Mol Med 2006;17(5):937-44
  • Chen J, Ye L, Zhang L, Jiang WG. The molecular impact of pigment epithelium-derived factor, PEDF, on lung cancer cells and the clinical significance. Int J Oncol 2009;35(1):159-66
  • Chen JF, Zhao W, Zhang JZ, Effects of pigment epithelial derived factor gene on growth of lung cancer cell and neovascularization: experiments with lung cancer cells and chick embryos. Zhonghua Yi Xue Za Zhi 2009;89(7):485-90
  • Cai J, Parr C, Watkins G, Decreased pigment epithelium-derived factor expression in human breast cancer progression. Clin Cancer Res 2006;12(11 Pt 1):3510-7
  • Doll JA, Stellmach VM, Bouck NP, Pigment epithelium-derived factor regulates the vasculature and mass of the prostate and pancreas. Nat Med 2003;9(6):774-80
  • Filleur S, Volz K, Nelius T, Two functional epitopes of pigment epithelial-derived factor block angiogenesis and induce differentiation in prostate cancer. Cancer Res 2005;65(12):5144-52
  • Guan M, Jiang H, Xu C, Adenovirus-mediated PEDF expression inhibits prostate cancer cell growth and results in augmented expression of PAI-2. Cancer Biol Ther 2007;6(3):419-25
  • Halin S, Wikstrom P, Rudolfsson SH, Decreased pigment epithelium-derived factor is associated with metastatic phenotype in human and rat prostate tumors. Cancer Res 2004;64(16):5664-71
  • Cheung LW, Au SC, Cheung AN, Pigment epithelium-derived factor is estrogen sensitive and inhibits the growth of human ovarian cancer and ovarian surface epithelial cells. Endocrinology 2006;147(9):4179-91
  • Phillips NJ, Ziegler MR, Radford DM, Allelic deletion on chromosome 17p13.3 in early ovarian cancer. Cancer Res 1996;56(3):606-11
  • Uehara H, Miyamoto M, Kato K, Expression of pigment epithelium-derived factor decreases liver metastasis and correlates with favorable prognosis for patients with ductal pancreatic adenocarcinoma. Cancer Res 2004;64(10):3533-7
  • Abe R, Shimizu T, Yamagishi S, Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo. Am J Pathol 2004;164(4):1225-32
  • Garcia M, Fernandez-Garcia NI, Rivas V, Inhibition of xenografted human melanoma growth and prevention of metastasis development by dual antiangiogenic/antitumor activities of pigment epithelium-derived factor. Cancer Res 2004;64(16):5632-42
  • Yang H, Xu Z, Iuvone PM, Grossniklaus HE. Angiostatin decreases cell migration and vascular endothelium growth factor (VEGF) to pigment epithelium derived factor (PEDF) RNA ratio in vitro and in a murine ocular melanoma model. Mol Vis 2006;12:511-7
  • Guan M, Pang CP, Yam HF, Inhibition of glioma invasion by overexpression of pigment epithelium-derived factor. Cancer Gene Ther 2004;11(5):325-32
  • Guan M, Yam HF, Su B, Loss of pigment epithelium derived factor expression in glioma progression. J Clin Pathol 2003;56(4):277-82
  • Zhang T, Guan M, Xu C, Pigment epithelium-derived factor inhibits glioma cell growth in vitro and in vivo. Life Sci 2007;81(16):1256-63
  • Quan GM, Ojaimi J, Nadesapillai AP, Resistance of epiphyseal cartilage to invasion by osteosarcoma is likely to be due to expression of antiangiogenic factors. Pathobiology 2002;70(6):361-7
  • Ek ET, Dass CR, Contreras KG, Choong PF. PEDF-derived synthetic peptides exhibit antitumor activity in an orthotopic model of human osteosarcoma. J Orthop Res 2007;25(12):1671-80
  • Ek ET, Dass CR, Contreras KG, Choong PF. Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clin Exp Metastasis 2007;24(2):93-106
  • Ek ET, Dass CR, Contreras KG, Choong PF. Pigment epithelium-derived factor overexpression inhibits orthotopic osteosarcoma growth, angiogenesis and metastasis. Cancer Gene Ther 2007;14(7):616-26
  • Kumar V, Abbas A, Fausto N. Robbins and Cotran pathologic basis of disease. 7th edition. Orlando: Elsevier Saunders; 2005
  • Liu W, Wu Z, Guan M, Lu Y. cDNA microarray analysis of pigment epithelium-derived factor-regulated gene expression profile in prostate carcinoma cells. Int J Urol 2009;16:323-8
  • Hase R, Miyamoto M, Uehara H, Pigment epithelium-derived factor gene therapy inhibits human pancreatic cancer in mice. Clin Cancer Res 2005;11(24 Pt 1):8737-44
  • Abe R, Fujita Y, Yamagishi S. Angiogenesis and metastasis inhibitors for the treatment of malignant melanoma. Mini Rev Med Chem 2007;7(6):649-61
  • Cao W, Tombran-Tink J, Chen W, Pigment epithelium-derived factor protects cultured retinal neurons against hydrogen peroxide-induced cell death. J Neurosci Res 1999;57(6):789-800
  • Yamagishi S, Inagaki Y, Amano S, Pigment epithelium-derived factor protects cultured retinal pericytes from advanced glycation end product-induced injury through its antioxidative properties. Biochem Biophys Res Commun 2002;296(4):877-82
  • Tsuru M, Arima N, Toyozumi Y, Kato S. Pigment epithelium-derived factor as a new diagnostic marker for melanocytic tumors. Kurume Med J 2005;52(3):81-7
  • Ek ET, Choong PF. The role of high-dose therapy and autologous stem cell transplantation for pediatric bone and soft tissue sarcomas. Expert Rev Anticancer Ther 2006;6(2):225-37
  • Takenaka K, Yamagishi S, Jinnouchi Y, Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci 2005;77(25):3231-41
  • Pillay V, Dass CR, Choong PF. The urokinase plasminogen activator receptor as a gene therapy target for cancer. Trends Biotechnol 2007;25(1):33-9
  • Dass CR, Nadesapillai AP, Robin D, Downregulation of uPAR confirms link in growth and metastasis of osteosarcoma. Clin Exp Metastasis 2005;22(8):643-52
  • de Bock CE, Lin Z, Itoh T, Inhibition of urokinase receptor gene expression and cell invasion by anti-uPAR DNAzymes in osteosarcoma cells. FEBS J 2005;272(14):3572-82
  • Dass CR, Choong PF. uPAR mediates anticancer activity of PEDF. Cancer Biol Ther 2008;7(8):1262-70
  • Kornberg LJ. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 1998;20(8):745-52
  • Dass CR, Contreras KG, Dunstan DE, Choong PFM. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. Biomaterials 2007;28:3026-33

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.